Massachusetts Financial Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$877M Buy
6,651,833
+370,224
+6% +$48.8M 0.28% 95
2026
Q1
$910M Buy
6,281,609
+2,058,305
+49% +$288M 0.31% 88
2025
Q4
$518M Buy
4,223,304
+4,113,999
+3,764% +$500M 0.17% 137
2025
Q3
$12.1M Sell
109,305
-4,986
-4% -$567K ﹤0.01% 676
2025
Q2
$12.7M Buy
114,291
+20,005
+21% +$2.13M ﹤0.01% 660
2025
Q1
$10.6M Buy
94,286
+18,368
+24% +$1.9M ﹤0.01% 656
2024
Q4
$7.01M Buy
75,918
+511
+0.7% +$46K ﹤0.01% 672
2024
Q3
$6.32M Sell
75,407
-10,397
-12% -$793K ﹤0.01% 663
2024
Q2
$5.89M Buy
85,804
+522
+0.6% +$34.8K ﹤0.01% 672
2024
Q1
$6.25M Buy
85,282
+295
+0.3% +$22.7K ﹤0.01% 654
2023
Q4
$6.88M Sell
84,987
-193,573
-69% -$15.1M ﹤0.01% 643
2023
Q3
$20.9M Buy
278,560
+3,228
+1% +$248K 0.01% 556
2023
Q2
$21.2M Sell
275,332
-108,468
-28% -$8.65M 0.01% 549
2023
Q1
$31.8M Sell
383,800
-150,760
-28% -$12.5M 0.01% 495
2022
Q4
$45.9M Sell
534,560
-30,003
-5% -$2.38M 0.02% 457
2022
Q3
$34.8M Sell
564,563
-11,465
-2% -$723K 0.01% 502
2022
Q2
$35.6M Buy
576,028
+11,850
+2% +$734K 0.01% 494
2022
Q1
$33.5M Buy
564,178
+303,523
+116% +$19.4M 0.01% 530
2021
Q4
$18.9M Buy
260,655
+82,245
+46% +$5.66M 0.01% 609
2021
Q3
$12.5M Sell
178,410
-283,556
-61% -$19.9M ﹤0.01% 657
2021
Q2
$31.8M Buy
461,966
+45,683
+11% +$3.05M 0.01% 568
2021
Q1
$26.9M Sell
416,283
-13,024
-3% -$840K 0.01% 575
2020
Q4
$25M Buy
429,307
+72,915
+20% +$4.4M 0.01% 568
2020
Q3
$22.5M Buy
+356,392
New +$24.7M 0.01% 558
2020
Q1
Sell
-5,739
Closed -$373K 811
2019
Q4
$373K Sell
5,739
-667
-10% -$43.4K ﹤0.01% 794
2019
Q3
$406K Buy
6,406
+558
+10% +$36.5K ﹤0.01% 803
2019
Q2
$395K Buy
5,848
+208
+4% +$13.7K ﹤0.01% 823
2019
Q1
$367K Sell
5,640
-836
-13% -$55.6K ﹤0.01% 823
2018
Q4
$405K Sell
6,476
-1,255
-16% -$87.7K ﹤0.01% 825
2018
Q3
$597K Buy
7,731
+2,728
+55% +$206K ﹤0.01% 816
2018
Q2
$354K Sell
5,003
-774
-13% -$54.7K ﹤0.01% 821
2018
Q1
$436K Sell
5,777
-1,719
-23% -$137K ﹤0.01% 811
2017
Q4
$537K Buy
7,496
+1,425
+23% +$108K ﹤0.01% 810
2017
Q3
$492K Sell
6,071
-1,358,988
-100% -$104M ﹤0.01% 805
2017
Q2
$96.6M Sell
1,365,059
-362,389
-21% -$24.1M 0.04% 269
2017
Q1
$117M Sell
1,727,448
-720,025
-29% -$50.6M 0.05% 235
2016
Q4
$175M Sell
2,447,473
-60,740
-2% -$4.51M 0.09% 196
2016
Q3
$198M Sell
2,508,213
-188,363
-7% -$15.3M 0.1% 189
2016
Q2
$225M Sell
2,696,576
-169,031
-6% -$15M 0.11% 173
2016
Q1
$263M Buy
2,865,607
+348,593
+14% +$31.4M 0.14% 156
2015
Q4
$255M Buy
2,517,014
+105,818
+4% +$11M 0.14% 158
2015
Q3
$237M Buy
2,411,196
+653,014
+37% +$72.5M 0.13% 154
2015
Q2
$206M Buy
1,758,182
+164,961
+10% +$18M 0.1% 179
2015
Q1
$156M Sell
1,593,221
-411,753
-21% -$41.8M 0.08% 204
2014
Q4
$189M Sell
2,004,974
-786,096
-28% -$81.3M 0.1% 187
2014
Q3
$297M Sell
2,791,070
-153,905
-5% -$15.1M 0.16% 143
2014
Q2
$244M Sell
2,944,975
-2,473,366
-46% -$193M 0.13% 163
2014
Q1
$384M Sell
5,418,341
-1,812,260
-25% -$142M 0.21% 105
2013
Q4
$543M Sell
7,230,601
-556,365
-7% -$38.7M 0.3% 83
2013
Q3
$490M Buy
7,786,966
+1,522,873
+24% +$91M 0.3% 83
2013
Q2
$321M Buy
+6,264,093
New +$327M 0.22% 98

Other funds holding GILD

Massachusetts Financial Services's GILD Position: Q2 2026 in Review

Massachusetts Financial Services increased its Gilead Sciences (GILD) stake by 5.9% in Q2 2026, buying an estimated $48.8M and bringing the position to 6,651,833 shares worth $877M. The position accounts for 0.28% of the portfolio, ranked #95.

Massachusetts Financial Services first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $910M in Q1 2026. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Massachusetts Financial Services held 6,651,833 shares of Gilead Sciences worth $877M as of Q2 2026.
  • Massachusetts Financial Services bought 370,224 Gilead Sciences shares in Q2 2026, an estimated $48.8M.
  • Gilead Sciences made up 0.28% of Massachusetts Financial Services's portfolio in Q2 2026, its #95 holding.
  • Massachusetts Financial Services first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
  • Massachusetts Financial Services's Gilead Sciences position peaked at $910M in Q1 2026.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.